Twelve Points Wealth Management LLC Amgen Inc Transaction History

Twelve Points Wealth Management LLC

$357 Million
Q1 2025

A detailed history of Twelve Points Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Twelve Points Wealth Management LLC holds 3,215 shares of AMGN stock, worth $930,195. This represents 0.28% of its overall portfolio holdings.

Number of Shares

3,215

Previous 3,246 0.96%

Holding current value

$930,195

Previous $846,000 18.32%

% of portfolio

0.28%

Previous 0.25%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$258.59 - $327.36 $8,016 - $10,148	-31 Reduced 0.96%	3,215 $1 Million
Q4 2024 Jan 22, 2025	BUY	$258.78 - $328.31 $356,598 - $452,411	1,378 Added 73.77%	3,246 $846,000
Q3 2024 Oct 16, 2024	BUY	$309.38 - $337.38 $47,335 - $51,619	153 Added 8.92%	1,868 $601,000
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $31,004 - $37,678	118 Added 7.39%	1,715 $535,000
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $8,334 - $10,061	-31 Reduced 1.9%	1,597 $454,000
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $22,245 - $25,096	87 Added 5.65%	1,628 $468,000
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $32,797 - $40,719	150 Added 10.78%	1,541 $414,000
Q2 2023 Jul 13, 2023	BUY	$214.27 - $253.37 $30,640 - $36,231	143 Added 11.46%	1,391 $308,000
Q1 2023 Apr 18, 2023	BUY	$225.79 - $275.2 $29,578 - $36,051	131 Added 11.73%	1,248 $301,000
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $1,832 - $2,328	-8 Reduced 0.71%	1,117 $0
Q3 2022 Oct 20, 2022	BUY	$224.46 - $253.15 $4,264 - $4,809	19 Added 1.72%	1,125 $254,000
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $23,071 - $25,674	100 Added 9.94%	1,106 $269,000
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $220,585 - $244,025	1,006 New	1,006 $243,000

Others Institutions Holding AMGN

# of Institutions

3,311

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twelve Points Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twelve Points Wealth Management LLC with notifications on news.

Account

Twelve Points Wealth Management LLC Amgen Inc Transaction History